Authorities in South Korea have confirmed that the country will begin giving out fourth doses of COVID-19 vaccines by the end of February 2022, Reuters news agency reported on Monday.
Health Minister Kwon Deok-cheol told a COVID-19 response meeting that high-risk groups will be the first to get the fourth dose, or a second booster shot.
According to transcript of the meeting, Kwon said: "We're planning to provide fourth shots to those who live in nursing homes and care facilities and others with declined immunisation, in light of a recent increase of infections among people aged 60 or older."
Reportedly, at least 44.22 million people, or 86.2 percent of the population of South Korea, are considered fully vaccinated.
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
Alzinova AB reports positive final Phase 1b results for ALZ-101 in Alzheimer's
Primrose Bio launches Prima RNApols ExTend RNA polymerase for long-template mRNA manufacturing
Merck's CAPVAXIVE approved by EC for pneumococcal disease prevention
Sanofi secures FDA fast track designation for chlamydia vaccine candidate
Anixa Biosciences secures US patent allowance for ovarian cancer vaccine
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
Everest Medicines' EVM14 IND application receives US FDA approval
Clover Biopharmaceuticals' SCB-1019 IND application receives US FDA approval
Centivax partners with Emery Pharma on universal flu vaccine
Avance Biosciences registers with CLIA program
GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine
hVIVO secures GBP2m contract for final stage of hMPV characterisation study
EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine